Treatment outcomes of curative radiotherapy in patients with vulvar cancer: results of the retrospective KROG 1203 study |
Kim, Youngkyong
(Proton Therapy Center, National Cancer Center)
Kim, Joo-Young (Proton Therapy Center, National Cancer Center) Kim, Ja Young (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Lee, Nam Kwon (Department of Radiation Oncology, Korea University Medical Center, Korea University College of Medicine) Kim, Jin Hee (Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine) Kim, Yong Bae (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) Kim, Young Seok (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Kim, Juree (Department of Radiation Oncology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine) Kim, Yeon-Sil (Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) Yang, Dae Sik (Department of Radiation Oncology, Korea University Medical Center, Korea University College of Medicine) Kim, Yeon-Joo (Proton Therapy Center, National Cancer Center) |
1 | Kirby TO, Rocconi RP, Numnum TM, et al. Outcomes of Stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. Gynecol Oncol 2005;98:309-12. DOI |
2 | Beriwal S, Coon D, Heron DE, et al. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecol Oncol 2008;109:291-5. DOI |
3 | De Hullu JA, Hollema H, Lolkema S, et al. Vulvar carcinoma: the price of less radical surgery. Cancer 2002;95:2331-8. DOI |
4 | American Cancer Society. Cancer Facts & Figures 2012. Atlanta, GA: American Cancer Society; 2012. |
5 | Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol 2008;108:577-83. DOI |
6 | Homesley HD, Bundy BN, Sedlis A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991;164:997-1003. DOI |
7 | Bell JG, Lea JS, Reid GC. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol 2000;77:314-8. DOI |
8 | Andersen BL, Hacker NF. Psychosexual adjustment after vulvar surgery. Obstet Gynecol 1983;62:457-62. |
9 | Gould N, Kamelle S, Tillmanns T, et al. Predictors of complications after inguinal lymphadenectomy. Gynecol Oncol 2001;82:329-32. DOI |
10 | Lin JY, DuBeshter B, Angel C, Dvoretsky PM. Morbidity and recurrence with modifications of radical vulvectomy and groin dissection. Gynecol Oncol 1992;47:80-6. DOI |
11 | Hoffman MS. Squamous-cell carcinoma of the vulva: locally advanced disease. Best Pract Res Clin Obstet Gynaecol 2003;17:635-47. DOI |
12 | Han SC, Kim DH, Higgins SA, Carcangiu ML, Kacinski BM. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2000;47:1235-44. DOI |
13 | Lee J, Kim SH, Kim G, et al. Treatment outcome in patients with vulvar cancer: comparison of concurrent radiotherapy to postoperative radiotherapy. Radiat Oncol J 2012;30:20-6. DOI |
14 | Tans L, Ansink AC, van Rooij PH, Kleijnen C, Mens JW. The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature. Am J Clin Oncol 2011;34:22-6. DOI |
15 | Landrum LM, Skaggs V, Gould N, Walker JL, McMeekin DS. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation. Gynecol Oncol 2008;108:584-90. DOI |
16 | Pinto AP, Schlecht NF, Pintos J, et al. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. Gynecol Oncol 2004;92:856-65. DOI |
17 | Oh D, Huh SJ. Insufficiency fracture after radiation therapy. Radiat Oncol J 2014;32:213-20. DOI |
18 | Moore DH, Ali S, Koh WJ, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol 2012;124: 529-33. DOI |
19 | Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 1998;42:79-85. DOI |
20 | Woelber L, Trillsch F, Kock L, et al. Management of patients with vulvar cancer: a perspective review according to tumour stage. Ther Adv Med Oncol 2013;5:183-92. DOI |
21 | National Cancer Institute (US). Common terminology criteria for adverse events (CTCAE) version 4.0. Bethesda, MD: National Institutes of Health, National Cancer Institute; 2009. |
22 | Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6. DOI |
23 | Beriwal S, Heron DE, Kim H, et al. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. Int J Radiat Oncol Biol Phys 2006;64:1395-400. DOI |
24 | Canavan TP, Cohen D. Vulvar cancer. Am Fam Physician 2002;66:1269-74. |
25 | Madeleine MM, Daling JR, Carter JJ, et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 1997;89:1516-23. DOI |
26 | Alonso I, Fuste V, del Pino M, et al. Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma? Gynecol Oncol 2011;122:509-14. DOI |
![]() |